The examination of data from the GSCA database and the cBioPortal database suggests that mutations are unlikely to be the causative factor for the abnormal overexpression of RPS5 in HCC (Supplementary Figure S3). This evidence concerns the gene RPS5 and hepatocellular carcinoma.